Abstract
In an attempt to elucidate the mechanisms underlying the regulation of bradykinin B2 receptor gene expression, the molecular structure of the rat gene including the 5'-flanking region was characterized (J. Biol. Chem. 269: 26920-26925, 1994). In this study we show that the gene spans about 32 kb, including a long first intron of 25 kb. The promoter region drives reporter gene expression in NG108-15 neuroglioma cells, and its expression is upregulated by cAMP, bradykinin, phorbol esters and by coexpression of an activated ras oncogene but not by dexamethasone.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
8-Bromo Cyclic Adenosine Monophosphate / pharmacology
-
Animals
-
Base Sequence
-
Bradykinin / pharmacology
-
DNA Primers / genetics
-
Gene Expression Regulation / drug effects
-
Genes, Regulator*
-
Genes, ras
-
Humans
-
Introns
-
Polymerase Chain Reaction
-
Promoter Regions, Genetic
-
Rats
-
Receptor, Bradykinin B2
-
Receptors, Bradykinin / genetics*
-
Sequence Homology, Nucleic Acid
-
Species Specificity
-
Tetradecanoylphorbol Acetate / pharmacology
-
Tumor Cells, Cultured
-
Up-Regulation / drug effects
Substances
-
DNA Primers
-
Receptor, Bradykinin B2
-
Receptors, Bradykinin
-
8-Bromo Cyclic Adenosine Monophosphate
-
Tetradecanoylphorbol Acetate
-
Bradykinin